Professional Summary

Professional Overview

Chris Cappella is an accomplished Chief Financial Officer with extensive experience in the pharmaceutical and diagnostic industries. As the CFO of Sysmex America, Inc., he is responsible for overseeing the company's financial strategy, operations, and compliance across North and South American markets. With a strong background in finance, accounting, and business partnering, Chris has demonstrated the ability to drive strategic initiatives and optimize financial performance.

Experience Summary

Current Role

As the Chief Financial Officer at Sysmex America, Inc., Chris Cappella is responsible for managing the company's financial operations, including budgeting, forecasting, and reporting. He plays a key role in aligning the company's financial strategy with its overall business objectives, ensuring efficient resource allocation and sound financial decision-making. Additionally, Chris serves as a Board Member and Company Officer for Sysmex's North and South American subsidiaries, contributing his expertise to the strategic direction and governance of these regional entities.

Career Progression

Prior to his current role, Chris held the position of Vice President Finance - Core Lab/POC Business Partner at Roche, where he partnered with business leaders to drive financial performance and support strategic initiatives. Earlier in his career, he gained valuable experience as a Finance Manager at Brightpoint and a Staff Accountant at Ernst & Young, developing a strong foundation in financial analysis, reporting, and compliance.

Academic Background

Chris Cappella holds a Bachelor's degree in Accounting, leveraging his specialized expertise to navigate the complex financial landscape of the pharmaceutical and diagnostic industries.

Areas of Expertise

• Financial strategy and planning

• Budgeting, forecasting, and reporting

• Business partnering and performance optimization

• Financial compliance and risk management

• Cross-functional collaboration and leadership

Professional Impact

Throughout his career, Chris has demonstrated the ability to positively impact organizations by implementing strategic financial initiatives and driving operational efficiencies. His strong analytical skills, coupled with a deep understanding of the industry, have enabled him to contribute to the success of leading companies in the diagnostics and pharmaceutical sectors.

Conclusion

With his extensive finance expertise, strategic leadership, and industry knowledge, Chris Cappella is well-positioned to continue driving financial excellence and supporting the growth of Sysmex America, Inc. and its subsidiaries in North and South America.